StonvexLoading…
StonvexStonvexStonvexCore line items from PLX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $52.74M | $53.40M | $65.49M | $47.64M |
Operating Income | $-5.50M | $3.92M | $10.46M | $-13.01M |
Net Income | $-6.60M | $2.93M | $8.31M | $-14.93M |
EPS (Diluted) | $-0.08 | $0.04 | $0.09 | $-0.31 |
Total Assets | $82.35M | $73.42M | $84.43M | $55.79M |
Total Liabilities | $34.12M | $30.21M | $50.87M | $66.43M |
Cash & Equivalents | $14.68M | $19.76M | $23.63M | $17.11M |
Free Cash Flow OCF − CapEx | $-13.63M | $7.39M | $-2.47M | $-25.63M |
Shares Outstanding | 80.43M | 75.85M | 72.95M | 53.79M |